Carsten Brunn
President and CEO at Cartesian Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cartesian Therapeutics Inc., 3 years.
Cartesian Therapeutics Inc.
Director · President and CEO
Chief executive roles
Cartesian Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2026 | Cartesian Therapeutics Inc. | Open-market sale | −23,766 | $6.82 | $162,084 |
| Jan 2, 2026 | Cartesian Therapeutics Inc. | Grant or award | +143,200 | — | — |
| Jan 6, 2025 | Cartesian Therapeutics Inc. | Open-market sale | −8,708 | $16.83 | $146,556 |
| Jan 3, 2025 | Cartesian Therapeutics Inc. | Open-market sale | −8,563 | $16.72 | $143,173 |
| Jan 2, 2025 | Cartesian Therapeutics Inc. | Grant or award | +57,500 | — | — |
| Jan 2, 2024 | Cartesian Therapeutics Inc. | Grant or award | +4,654,100 | — | — |
| Nov 13, 2023 | Cartesian Therapeutics Inc. | Sold back to the company | −55,000 | $2.06 | $113,300 |
| Nov 13, 2023 | Cartesian Therapeutics Inc. | Sold back to the company | −13,600 | $2.06 | $28,016 |
| Nov 13, 2023 | Cartesian Therapeutics Inc. | Sold back to the company | −169,725 | $2.06 | $349,634 |
| Nov 13, 2023 | Cartesian Therapeutics Inc. | Sold back to the company | −282,800 | $2.06 | $582,568 |
| Sep 25, 2023 | Cartesian Therapeutics Inc. | Open-market sale | −2,932 | $1.06 | $3,108 |
| Jan 5, 2023 | Cartesian Therapeutics Inc. | Open-market sale | −13,396 | $1.13 | $15,137 |
| Jan 5, 2023 | Cartesian Therapeutics Inc. | Open-market sale | −77 | $1.12 | $86 |
| Jan 4, 2023 | Cartesian Therapeutics Inc. | Open-market sale | −27,549 | $1.13 | $31,130 |
| Jan 4, 2023 | Cartesian Therapeutics Inc. | Open-market sale | −48 | $1.15 | $55 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.